Cellectis (NASDAQ: CLLS) reported Q2 EPS of ($0.19), $0.25 better than the analyst estimate of ($0.44). Revenue for the quarter came in at $2 million versus the consensus estimate of $4.48 million.

For earnings history and earnings-related data on Cellectis (CLLS) click here.